Approval · Notice of Compliance 4976 · 1995
DOVONEX: Notice of Compliance 4976
Issued February 7, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4976
- Date
- February 7, 1995
- Company
- Leo Laboratories Canada Ltd.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form
- Therapeutic class
- Antipsoriatic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOVONEX | 02150956 | Cancelled Post Market |
Medicinal ingredients
- CALCIPOTRIOL 50 MCG per G